End-consumer Benefits
Phase | Ingredient | Quantity (%) |
A | Polyglyceryl-3 methylglucose Distearate | 1.00 |
A | Butyl methoxydibenzoylmethane | 3.00 |
A | Octocrylene | 10.00 |
A | Ethylhexyl salicylate | 5.00 |
A | Homosalate | 10.00 |
A | Neopentyl Glycol Diheptanoate | 2.50 |
A | C12-15 alkyl Benzoate | 2.50 |
A | Dimethicone | 1.00 |
A | Xanthan Gum | 0.20 |
A | Cetearyl alcohol | 1.00 |
A | Phenoxyethanol (and) ethylhexylglycerin | 1.00 |
B | Water | 52.25 |
B | Glycerin | 3.00 |
B | Disodium EDTA | 0.05 |
C | Baycusan® C 1000 | 7.50 |
Description
- In vivo SPF (international test method on 10 volunteers) = 36.0
- Water-resistant formulation (Colipa test method on 10 volunteers)
Procedure
- The phase B is heated to 80°C under stirring.
- In a separate vessel, the phase A is mixed while heating to 80°C.
- When the phases are uniform, the phase A is added to the phase B under continuous mixing. The emulsion is homogenized.
- At 25°C, phase C is added and mixed. The emulsion is homogenized.